COVID-19 Useful Links

COVID-19 Useful Links

Useful links are published here to relevant general information from our network partners and beyond, regionally and globally, regarding COVID-19 policy and regulatory recommendations. These include respective technical guidance from the county-by-country government level, to public advice on appropriate measures to mitigate viral spread.

As this is an evolving situation, please bookmark and refer back to this page for updated information.

 

  • Common European response to the coronavirus outbreak (European Commission). https://ec.europa.eu/info/live-work-travel-eu/health/coronavirus-response_en

  • European Centre for Disease Prevention and Control (ECDC). Covid-19 overview and outputs. https://www.ecdc.europa.eu/en/covid-19-pandemic

  • Norwegian Institute of Public Health (NIPH) / Cochrane Effective Practice and Organisation of Care (EPOC). Three new evidence-based information leaflets for health system planners and implementers. Communicating to the public about vaccines and using digital strategies to promote vaccine uptake: information for planners and implementers.

  • The Joint Research Centre (JRC) COVID-19 In Vitro Diagnostic Devices and Test Methods database (https://covid-19-diagnostics.jrc.ec.europa.eu/). The database collects in a single place all publicly available information on performance of CE-marked in vitro diagnostic medical devices (IVDs) as well as in-house laboratory-developed devices, kits and related test methods for coronavirus SARS-CoV-2. The COVID-19 in vitro diagnostic medical devices part contains publicly available in vitro diagnostic medical devices for COVID-19 and it is being updated periodically.

  • “COVID – Research to Policy Action” platform (hosted by the Health Policy Platform https://webgate.ec.europa.eu/hpf/) which aims to ensure the rapid contribution of relevant research findings to public health policy for the pandemic response in Europe. The platforms is dedicated to 5 projects funded through the January 2020 emergency call of Horizon 2020 (I-MOVE-COVID-19, RECOVER, HERoS, EpiPose and CORESMA), and allows secure exchange of information between their partners, ECDC and EC services (DG RTD, DG SANTE). Interested EUnetHTA partners are welcome to apply to get access to this platform.

  • EU COVID-19 Convalescent Plasma database /EUCCP (https://ec.europa.eu/health/blood_tissues_organs/covid-19_en). An initiative from Commission services (DG SANTE, DG DIGIT) and the European Blood Alliance/EBA, the database allows for entering data from collections and transfusions of CCP used for treating patients with severed forms of COVID19 within fully structured and registered clinical trials (without interfering with the plans in these trials) and from monitored use outside these trials. It also ensures support for analysis and sharing of data.

  • Dutch Horizon Scanning (in Dutch). Organised by the Dutch Healthcare Institute (ZIN), Horizon Scan Medicines is an integral, public and as objective as possible overview of which innovative medicines are expected on the market and their possible impact. https://www.horizonscangeneesmiddelen.nl

  • McMaster Health Forum. Covid-19 Evidence Network to Support Decision-Making. https://www.mcmasterforum.org/networks/covid-end
Country
Organisation
Description
Link to Publication
General
European Medicines Agency (EMA)
EMA’s safety committee (PRAC) has started a review of a safety signal to assess reports of acute kidney injury in some patients with COVID-19 taking Veklury (remdesivir).
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 September – 1 October 2020
PRAC Reviews a sginal with Veklury
General
International
Cross-country analysis of health system responses and key policy lessons.
World Health Organization + European Commission + European Observatory on Health Systems and Policies
Germany
IQWiG
Unterstützung in der Corona-Krise (Understanding in the Corona crisis)
Unterstützung in der Corona-Krise
Ireland
Health Information and Quality Authority (HIQA)
Rapid health technology assessment (HTA) of the alternatives to laboratory-based real-time reverse-transcription polymerase chain reaction (rRT-PCR) to diagnose current infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Rapid HTA of alternative tests to detect current infection with SARS-CoV-2
Ireland
Health Information and Quality Authority (HIQA)
To inform national efforts in response to COVID-19, HIQA is developing evidence summaries to answer specific research questions posed by the National Public Health Emergency Team.
Evidence Summary for COVID-19 Clinical Samples
Ireland
Health Information and Quality Authority (HIQA)
HIQA’s HTA team is supporting the National Public Health Emergency Team in its response to COVID-19.
Health Technology Assessments
Ireland
Health Information and Quality Authority (HIQA)
To inform the ongoing response to the Covid-19 pandemic, specifically, to inform the development of public health guidance to prevent the spread of Covid-19, HIQA has created a database of Covid-19 public health guidance produced by international organisations.
Database of public health guidance on COVID-19
Italy
AIFA
Vaccini COVID-19 | Agenzia Italiana del Farmaco (aifa.gov.it)
Vaccini COVID-19
Norway
NIPHNO
The main map gives an overview of all publications categorized according to publication type, population of interest and topic.
NIPH systematic and living map on COVID-19 evidence
Spain
AEMPS
Ensayos clínicos autorizados sobre COVID-19
Clinical researches overview